Search results
Results from the WOW.Com Content Network
The Bethesda system (TBS), officially called The Bethesda System for Reporting Cervical Cytology, is a system for reporting cervical or vaginal cytologic diagnoses, [1] used for reporting Pap smear results. It was introduced in 1988 [2] and revised in 1991, [3] 2001, [1] [4] [5] and 2014. [6]
The Papanicolaou test (abbreviated as Pap test, also known as Pap smear (AE), [1] cervical smear (BE), cervical screening (BE), [2] or smear test (BE)) is a method of cervical screening used to detect potentially precancerous and cancerous processes in the cervix (opening of the uterus or womb) or, more rarely, anus (in both men and women). [3]
If you get an abnormal result from your pap test, don’t panic: “Many women have abnormal cervical cancer screening results and an abnormal result does not mean that you have cancer ...
Cervical cancer screening is a medical screening test designed to identify risk of cervical cancer. Cervical screening may involve looking for viral DNA, and/or to identify abnormal, potentially precancerous cells within the cervix as well as cells that have progressed to early stages of cervical cancer .
My heart sunk when I read the letter. I had tested positive for HPV and my smear test result was "inadequate". I could almost hear my pulse thudding in my chest. I had no idea what this result ...
The task force has introduced a recommendation that women over the age of 30 test for high-risk human papilloma viruses (HPV) every five years rather than relying on pap smears to detect cervical ...
The most common investigation in this field is the Pap test, which is used to screen for potentially precancerous lesions of the cervix. Cytology can also be used to investigate disorders of the ovaries, uterus, vagina and vulva. Gynaecologic cytology makes frequent use of the Bethesda system in order to grade the results of HPV testing. [2]
Cervical cancer screening, such as with the Papanicolaou test (pap) or looking at the cervix after using acetic acid, can detect early cancer or abnormal cells that may develop into cancer. This allows for early treatment which results in better outcomes. [ 1 ]